Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
237.1 USD | +0.77% | +3.64% | +0.40% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.40% | 12.08B | |
+19.73% | 46.81B | |
-0.69% | 41.37B | |
+47.07% | 41.29B | |
-6.20% | 28.87B | |
+11.71% | 26.06B | |
-19.81% | 19.13B | |
+32.64% | 12.39B | |
+0.48% | 11.96B | |
+19.35% | 11.56B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Guggenheim Upgrades Charles River Laboratories International to Buy From Neutral, $255 Price Target